MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress » Functional (Psychogenic) Movement Disorders

Date: Monday, September 23, 2019

Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Meeting: 2019 International Congress

1:45pm-3:15pm
Altered intrinsic power spectral density of the precuneus in patients with hyperkinetic functional movement disorders

R. Marapin, H. Horn, J. Gelauff, B. de Jong, Y. Dreissen, J. Koelman, R. Renken, J. Marsman, M. Tijssen (Groningen, Netherlands)

1:45pm-3:15pm
Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)

1:45pm-3:15pm
Can a smartphone accelerometer differentiate between functional and organic tremor ?

M. Khider Ahmed, T. Mouton, J. Ackerman, N. Brey, C. Albertyn, F. Henning, J. Carr (Cape Town, South Africa)

1:45pm-3:15pm
Clinical hypnosis in functional movement disorders: a potential therapeutic strategy

C. Buiza-Aguado, C. Ordas-Bandera, M. Guillan-Rodriguez, J. Del Val, PJ. Garcia Ruiz-Espiga, JC. Martinez-Castrillo, I. Parees-Moreno, A. Alonso-Canovas (Madrid, Spain)

1:45pm-3:15pm
Clinical spectrum of Functional Movement Disorders: A clinic based study from a developing country

D. Dash, M. Tripathi, R. Singh (Delhi, India)

1:45pm-3:15pm
Functional exam findings in Lewy Body Disease

J. Nguyen, K. Papesh (Las Vegas, NV, USA)

1:45pm-3:15pm
FUNCTIONAL MOTOR SYMPTOMS IN PARKINSON’S DISEASE, AND FUNCTIONAL PARKINSONISM: A SYSTEMATIC REVIEW

M. Ambar Akkaoui, P. Geoffroy, E. Roze, B. Degos, B. Garcin (Bobigny, France)

1:45pm-3:15pm
Functional stiff person like disorders: clinical features and red flags

B. Balint, A. Jha, M. Edwards, HM. Meinck, K. Bhatia (London, United Kingdom)

1:45pm-3:15pm
Healthcare utilization and emergency department/inpatient costs in adult and pediatric functional neurological disorders

C. Stephen, C. Lungu, A. Espay (Boston, MA, USA)

1:45pm-3:15pm
Incongruity of Functional Tremor Predicts Better Response to Transcranial Magnetic Stimulation Treatment

N. Prezelj, K. Vogelnik, Z. Pirtošek, M. Kojović (Ljubljana, Slovenia)

1:45pm-3:15pm
Integrated therapy for Functional Movement Disorders: results from a pilot clinic

S. Lidstone, L. Macgillivray, C. Marras, M. Josef, L. Muc, A. Lang (Toronto, ON, Canada)

1:45pm-3:15pm
Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders

A. Kompoliti, C. Hebert, J. Behel, G. Pal, R. Kasi (Chicago, IL, USA)

1:45pm-3:15pm
Management of Patients with Functional Movement Disorders: A Transcultural Perspective

C. Maurer, D. Anderson, A. Asadi-Pooya, J. Baizabal, M. Damianova, C. Ganos, R. Kanaan, M. Tijssen, J. Kwasa, I. Moreno, S. Pandey, JE. Park, D. Saylor, M. Stamelou, C. Stephen, T. Teodoro, M. Tinazzi, K. Lafaver (Stony Brook, NY, USA)

1:45pm-3:15pm
Neuropsychological profile of patients with functional movement disorders

G. Vechetova, T. Nikolai, M. Slovak, Z. Hanzlikova, M. Vranka, E. Bolcekova, T. Teodoro, E. Ruzicka, M. Edwards, T. Serranova (Prague, Czech Republic)

1:45pm-3:15pm
Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019

K. Lafaver, D. Bega, M. Hallett, A. Lang, S. Lidstone, C. Maurer, F. Morgante, D. Perez, C. Stephen, J. Stone, T. Teodoro, A. Wu, A. Dwivedi, A. Espay (Louisville, KY, USA)

1:45pm-3:15pm
Potential treatment considerations for refractory REM behavior disorder

J. Nguyen, K. Papesh (Las Vegas, NV, USA)

1:45pm-3:15pm
Preoperative quantitative evaluation of psychological determinants in abnormal head postures

E. Sanrey, C. Labate, L. Cif, V. Gonzalez, E. Borgeais, E. Chan Seng, P. Coubes (Montpellier, France)

1:45pm-3:15pm
rTMS-induced effects on Functional Tremor: a randomized, double-blind, controlled study

S. Taib, F. Ory-Magne, C. Brefel-Courbon, Y. Moreau, C. Thalamas, C. Arbus, M. Simonetta-Moreau (Toulouse, France)

1:45pm-3:15pm
The effect of intranasal oxytocin in patients with functional motor symptoms: an open label case series

B. Demartini, D. Goeta, D. Di Benedetto, A. Casiraghi, D. Mazza, A. Priori, O. Gambini (Milano, Italy)

1:45pm-3:15pm
The role of attention in functional movement disorders

A. Huys, P. Haggard, K. Bhatia, M. Edwards (London, United Kingdom)

1:45pm-3:15pm
The role of stress-related genes and childhood trauma in the clinical phenotype of Functional Movement Disorders

P. Spagnolo, C. Maurer, G. Norato, C. Hodgkinson, M. Hallett (Bethesda, MD, USA)

1:45pm-3:15pm
What do medical students think about functional movement disorders?

JB. Paredes, E. Villalba, A. Canovas, JL. Sendon, P. Torre, S. Argos, S. Madrona, J. Poles, V. Hristova, L. García, JC. Castrillo, I. Moreno (Madrid, Spain)

« View all sessions from the 2019 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley